Run-to-Run Control Strategy for Diabetes Management by Doyle III, F. J. et al.
1RUN-TO-RUN CONTROL STRATEGY FOR DIABETES MANAGEMENT
F.J. Doyle III
1
, B. Srinivasan
2
, and D. Bonvin
2
1
Department of Chemical Engineering, University of Delaware, Newark DE, USA
2
Institut d'Automatique, EPFL, Lausanne, Switzerland
Email of corresponding author: fdoyle@udel.edu
Abstract { An approach to insulin injection ther-
apy is introduced that draws from recent ideas
in run-to-run control of batch chemical reactors.
An analogy is drawn between repeated meal pro-
les for a diabetic patient and repeated operations
of typical batch reactor recipes. The method re-
lies on measurements of blood glucose and does
not require a mathematical model. Results are
shown for simulation case studies involving a de-
tailed pharmacokinetic model.
Keywords { Diabetes control, glucose control, run-to-run
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I. Introduction
Type I diabetes mellitus has received considerable at-
tention in biomedical research, owing to the large fraction
of the population which is aected by the disease (current
estimate is 16 million worldwide). The primary manifes-
tation of the disease is large uctuations in the patient's
blood glucose level. Short term implications of low glu-
cose levels are quite serious (diabetic coma), and the long-
term implications of varying glucose levels (nephropathy,
retinopathy, and other tissue damage ) have received in-
creasing attention in such forums as the Diabetes Control
and Complications Trial (DCCT) [1], [2].
The approaches to glucose regulation are varied, with
the conventional method consisting of 3-5 daily insulin
injections with quantities of insulin based on 4-8 daily in-
vasive glucose measurements. To date, this form of ther-
apy has been unable to restore metabolism to a healthy
patient state, and wide glucose uctuations continue to
occur for many patients. According to the DCCT, blood
glucose should be controlled within the range of 60{120
mg/dl. Research is underway for alternative methods,
including beta cell transplants, insulin pumps, and oral
or nasal delivery means. A survey of some of these ap-
proaches can be found in [3] and [4].
Control theoretic developments have focused primarily
on the insulin pump regimens, with some of the early work
dating to the BIOSTATOR
TM
algorithm [5]. One of the
early studies considered a hybrid formulation of an injec-
tion combined with continuous delivery [6]. However, the
injection timing and amount were xed in that analysis.
A key issue in control studies is the source of the insulin
injection, either intravenous or subcutaneous. A nice re-
view of the two areas is provided in a pair of recent articles
([3], [4]). Two key issues are the ease with which insulin
can be administered in the respective sites, and the rela-
tively longer time constant associated with the uptake of
insulin delivered subcutaneously.
Another trend in the diabetes management area is the
increasing availability of glucose measurement informa-
tion for the patient. Recent developments include the
AccuChek system from Roche Diagnostics and the Glu-
coWatch from Cygnus. Although these systems do not
provide a continuous glucose reading, the frequency rates
are approaching several samples per hour, which is an ef-
fective range for a system response that is on the order
of several hours. There is an unprecedented amount of
information available for the patients to use in the cus-
tomization of their insulin therapy.
II. Patient Protocol as a Batch-to-Batch
Control Problem
We propose in this paper a technique for optimizing
a patient's insulin therapy (timing, amount) through the
use of so-called run-to-run control [7]. This technique has
found application in the chemical industry for the opti-
mal operation of batch reactors which undergo repeated
executions of a similar recipe.
The similarities between the diabetic patient protocol
and the batch reactor recipe which motivate the applica-
tion of this technique are:
 the recipe (24-hour cycle) for a human patient con-
sists of a repeated meal protocol (typicall 3 meals)
with some variance on meal type, timing, and dura-
tion,
 there is not an accurate dynamic model available to
describe the detailed glucose response for an individ-
ual to the meal prole, and
 there are selected measurements available which
might be used to characterize the \quality" of the
response for a 24-hour day, including maximum and
minimum glucose values.
As noted in the original reference [7], the key elements
of the algorithm are that it is measurement-based (as op-
posed to model-based) and the independent variable of
the control loop is the batch number. Thus, the solu-
tion is implemented as an open-loop policy for each batch
(24-hour cycle), and the feedback allows renement over
successive batches (days).
Of particular interest in the present context is the fact
that the limited measurement information of the patient's
blood glucose level is translated into quality measure-
ments (max/min glucose). In this way, the patient's sam-
pling protocol does not need to be rigorously synchro-
nized to a particular time every day, and the correspond-
ing quality variables are exactly the type of variables that
a medical professional would use to evaluate the eÆciency
of a particular insulin regimen.
A. Description of the procedure
The basic procedure from [7] is summarized below:
1. Parameterize the input prole for batch k, u(t; k),
as U(t; (k)) such that the input parameter vector,
(k), and the controlled variable vector,  (k), have
the same dimension.
2. Choose an initial guess for (k); k = 1.
3. Run the batch using the input u(t; k) correspond-
ing to (k). Compute  (k) from the measurements,
y(t; k).
4. Update the input parameters using (k+1) = (k)+
K ( 
r
   (k)), with K being an appropriate gain
matrix and  
r
the reference values to be attained.
Set k = k+1 and repeat steps 3-4 until convergence.
For the present application, u(t; k) and y(t; k) corre-
spond to the insulin and glucose proles, respectively.
Two cases will be considered: a repeated single-meal and
a three-meal 24-hour cycle. The running index k repre-
sents the cycle number, i.e., the meal number in the rst
case and the day number in the second. The choice of
(k) and  (k) depends on the case considered and will be
discussed next.
B. Single meal study
The two manipulated variables and the two controlled
variables in this case are as follows:
 Manipulated variables: timing of insulin injection, T ,
and quantity of insulin injection, Q, i.e., 
T
= [T Q ].
 Controlled variables: maximum value of glucose at-
tained after the meal, G
max
, and minimum value of
glucose attained after the peaking, G
min
, i.e.,  
T
=
[G
max
G
min
]. The maximum and minimum glucose
concentrations are selected as convenient scalar mea-
sures of performance for a particular insulin regime.
In principle, a multivariable controller could be de-
signed to maintain the two components of  at their
reference values  
r
. However, the eects of the inputs
are relatively decoupled for the case studies considered
(as determined by the relative gain array (RGA)). The
RGA analysis suggests a strategy which pairs the timing
of insulin T with maximum value of glucose G
max
, and
the quantity of insulin Q with minimum value of glucose
G
min
. So, the update laws for the timing and quantity of
insulin injection are given below:
T (k + 1) = T (k) +K
T
min(0; (G
r
max
 G
max
(k)))(1)
Q(k + 1) = Q(k) +K
Q
max(0; (G
r
min
 G
min
(k)))(2)
Note that the controller used is of the integral type.
To improve the rate of convergence, a proportional or a
derivative term can be added, thus resulting in a PI or a
PID controller, for the design of which standard controller
design methodologies can be used.
A specic attribute of this problem is that any value of
G
max
(k) less than G
r
max
is acceptable. So, no correction
needs to be done when (G
r
max
 G
max
(k)) is positive. A
similar situation arises with G
min
also, where no correc-
tion is necessary when (G
r
min
 G
min
(k)) is negative.
The important variables that need to be designed are
the initial values T (1) and Q(1). In addition to G
r
max
and G
r
min
(desirable bounds on glucose), there exist hard
limits

G
max
and

G
min
(absolute bounds that, if violated,
lead to serious medical problems). The values T (1) and
Q(1) should be so chosen that these hard constraints are
satised for all cases. Also, the history of the patient can
help choose initial values close enough to the eventual nal
values.
The gains K
T
and K
Q
are the next important param-
eters that have to be computed. Though the coupling
is low, it might so happen that a fast decrease in G
max
may cause an unacceptable dip in G
min
and vice-versa.
Thus, the gains reect a compromise between speed and
accuracy.
C. Extension to 24-hour cycle
The previous study introduced the basic elements of the
algorithm. One rather weak implicit assumption is that
all meals appear similar. That assumption is relaxed here,
where 3 meals are considered over a 24-hour period as the
basic cycle which is repeated.
In a normal day, there are three meals, each of which has
fairly dierent caloric content. Thus the timing and the
quantity of insulin used need to be dierent and adapted
to the food habits. Thus, there are 6 manipulated vari-
ables (T and Q for each meal) and 6 controlled variables
(G
max
and G
min
for each meal). This gives rise to a
6 6 multivariable control problem. However, as before,
there is very strong decoupling between manipulated and
controlled variables. Also, the morning meal and insulin
intake have negligible inuence on the glucose evolution
during lunch and dinner. The mathematical details of
the control development parallel the previous case, with
the obvious increase in dimension, and are omitted in this
paper. The application of this algorithm to a simulation
patient model is reported in the next section.
III. Simulated Patient Case Study
The case study utilizes a detailed (19th order) com-
partmental model as a virtual patient to demonstrate the
algorithm [9], [10]. The full model consists of 6 compart-
ments to describe the metabolism of glucose and insulin in
the body, with several compartments subdivided into sep-
arate tissue and capillary subspaces. The model is used
to relate two inputs (meal ingestion, intravenous insulin
injection) to the key output (blood glucose). The partic-
ular parameter values and operating conditions employed
in this simulation are detailed in [10].
As discussed earlier, the RGA calculated between the
manipulated inputs (insulin timing/amount) and outputs
(max/min glucose) is eectively diagonal:
RGA
Sorensen
=

1:0126  0:0126
 0:0126 1:0126

The reference values were 122 mg/dl for maximum glu-
cose and 83:5 mg/dl for the minimum glucose (nominal
patient has a basal glucose value of 87 mg/dl). The hard
constraints that were imposed on the glucose range were
207 and 72, respectively.
The results of this case study are summarized in Fig-
ures 1 through 4. The rst gure depicts the nal (opti-
mal) insulin prole determined after 20 meals. The pro-
gressive improvement is depicted in the next 2 gures
which show the maximum and minimum glucose values,
respectively. It can be seen that the \optimal" maximum
glucose is achieved after several meals, while the \opti-
mal" minimum glucose level is achieved rather quickly.
The uctuations which appear in the proles are the par-
tially the result of a random signal (approximately 5 per
cent relative standard deviation) employed for the actual
meal size. Figure 4 shows the resulting glucose prole
after the last iteration.
With regard to an actual patient trial, these results sug-
gest that a relatively short trial period could be employed
(2-3 days) after which the patient's new regimen could be
established. In this manner, the proposed approach could
be used either in a continuous fashion for constant ne-
tuning, or on a periodic basis to allow \re-calibration".
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Fig. 1. Insulin injection prole calculated for a single meal response
A. Extension to 24-hour cycle
The same simulation model was utilized in the more
practical setting of a 3-meal (batch) cycle. The relative
gain array supports a decentralized strategy which pairs
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Fig. 2. Maximum glucose level versus iteration for a single meal
response
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Fig. 3. Minimum glucose level versus iteration for a single meal
response
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Fig. 4. Blood glucose prole calculated for a single meal response
insulin dosage and timing with the corresponding mini-
mum/maximum of the corresponding meal response. For
the purposes of this study, the controller gains as the same
for each meal { hence there are only two \tuning" knobs
for this controller.
The results are summarized in Figures 5 and 6. The
nal insulin prole after 10 cycles (days) is depicted in
Figure 5. The corresponding optimal glucose prole is
shown in Figure 6. It can be seen that the hypoglycemic
excursions are quite small, and the hyperglycemic excur-
sions are in an acceptable range.
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Fig. 5. Insulin injection prole calculated for a three meal response
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Fig. 6. Blood glucose prole calculated for a three meal response
IV. Conclusions and Extensions
An approach to optimal insulin injection therapy for
a diabetic patient is presented. The idea draws inspira-
tion from batch-to-batch control strategies in the chemical
process industry, and has been extended to the drug de-
livery context in this paper. The results show promise for
both single meal and single day (3 meal) cycles. The con-
vergence to an optimal insulin prole is typically accom-
plished in 5-10 cycles. Two of the particularly attractive
features of the approach are: (i) there is no requirement
for a mathematical model, and (ii) the measurement re-
quirements are fairly modest (no high frequency, real-time
measurements needed). The variables chosen for \qual-
ity" reect the key medical attributes of the patient re-
sponse (maximum and minimum glucose response).
The results could be generalized to a wide variety of
drug delivery problems that contain some repetitive cycle
of response to either a cyclic disturbance or a cyclic refer-
ence. The robustness of the approach to variations in the
cycle (for example, meal timing and amount) is currently
under investigation. An additional point for further in-
vestigation is the incorporation of a detailed description
for subcutaneous transport of insulin in the patient model
to more accurately reect a standard insulin injection re-
sponse.
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